| Primary |
| Hypertension |
53.9% |
| Drug Use For Unknown Indication |
9.0% |
| Intentional Overdose |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Paralysis |
3.4% |
| Supplementation Therapy |
3.4% |
| Anaesthesia |
2.2% |
| Arthritis |
2.2% |
| Hyperlipidaemia |
2.2% |
| Normal Pressure Hydrocephalus |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Analgesia |
1.1% |
| Atrial Fibrillation |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Blood Pressure |
1.1% |
| Blood Pressure Increased |
1.1% |
| Catheter Placement |
1.1% |
| Coronary Artery Disease |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Glaucoma |
1.1% |
|
| Medication Error |
8.0% |
| Mental Impairment |
8.0% |
| Product Substitution Issue |
8.0% |
| Renal Failure Acute |
8.0% |
| Suicide Attempt |
8.0% |
| Abscess |
4.0% |
| Acute Generalised Exanthematous Pustulosis |
4.0% |
| Cough |
4.0% |
| Death |
4.0% |
| Drug Abuse |
4.0% |
| Drug Interaction |
4.0% |
| Dry Mouth |
4.0% |
| Extrasystoles |
4.0% |
| Fatigue |
4.0% |
| Feeling Cold |
4.0% |
| Henoch-schonlein Purpura |
4.0% |
| Hyperkalaemia |
4.0% |
| Hypertension |
4.0% |
| Hypokalaemia |
4.0% |
| Inappropriate Schedule Of Drug Administration |
4.0% |
|
| Secondary |
| Hypertension |
39.9% |
| Product Used For Unknown Indication |
13.0% |
| Drug Use For Unknown Indication |
10.6% |
| Type 2 Diabetes Mellitus |
7.0% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Normal Pressure Hydrocephalus |
3.1% |
| Pain |
3.1% |
| Hyperlipidaemia |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Glaucoma |
2.1% |
| Ischaemic Heart Disease Prophylaxis |
1.8% |
| Sinus Disorder |
1.6% |
| Hypertension Arterial |
1.3% |
| Myelodysplastic Syndrome |
1.3% |
| Antibiotic Prophylaxis |
1.0% |
| Maternal Exposure During Pregnancy |
1.0% |
| Rosacea |
1.0% |
| Secondary Hypertension |
1.0% |
| Acute Myeloid Leukaemia |
0.8% |
| Blood Pressure Increased |
0.8% |
|
| Renal Failure Acute |
16.2% |
| Vomiting |
14.7% |
| Completed Suicide |
7.4% |
| Hyponatraemia |
5.9% |
| Single Functional Kidney |
5.9% |
| Inappropriate Schedule Of Drug Administration |
4.4% |
| Nasal Oedema |
4.4% |
| Scar |
4.4% |
| Thrombocytopenia |
4.4% |
| Bronchopneumopathy |
2.9% |
| Cardiac Arrest |
2.9% |
| Drug Interaction |
2.9% |
| Flatulence |
2.9% |
| Haemolytic Anaemia |
2.9% |
| Hepatorenal Syndrome |
2.9% |
| Hypertension |
2.9% |
| Poisoning |
2.9% |
| Right Ventricular Failure |
2.9% |
| Serum Ferritin Increased |
2.9% |
| Syncope |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
18.5% |
| Hypertension |
15.1% |
| Rheumatoid Arthritis |
6.8% |
| Pain |
4.0% |
| Diabetes Mellitus |
3.6% |
| Blood Cholesterol Increased |
2.9% |
| Hiv Infection |
2.4% |
| Osteoarthritis |
2.3% |
| Breast Cancer |
2.1% |
| Hormone Replacement Therapy |
2.0% |
| Premedication |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Depression |
1.8% |
| Blood Pressure Abnormal |
1.8% |
| Asthma |
1.6% |
| B-cell Lymphoma |
1.6% |
| Bipolar Disorder |
1.6% |
| Osteoporosis |
1.6% |
| Hypothyroidism |
1.4% |
|
| Pain |
7.5% |
| Type 2 Diabetes Mellitus |
7.5% |
| Oedema Peripheral |
6.5% |
| Thrombocytopenia |
6.5% |
| Vomiting |
6.5% |
| Pruritus |
5.6% |
| Diarrhoea |
4.7% |
| Lung Disorder |
4.7% |
| Lymphopenia |
4.7% |
| Myocardial Infarction |
4.7% |
| Pain In Extremity |
4.7% |
| Thrombosis |
4.7% |
| Vasculitis |
4.7% |
| Weight Increased |
4.7% |
| Bile Duct Cancer |
3.7% |
| Death |
3.7% |
| Deep Vein Thrombosis |
3.7% |
| Drug Interaction |
3.7% |
| Headache |
3.7% |
| Hypoaesthesia |
3.7% |
|
| Interacting |
| Hypertension |
37.3% |
| Type 2 Diabetes Mellitus |
19.9% |
| Drug Use For Unknown Indication |
8.4% |
| Glaucoma |
6.6% |
| Ischaemic Heart Disease Prophylaxis |
6.6% |
| Pain |
6.6% |
| Hyperlipidaemia |
6.0% |
| Blood Pressure Abnormal |
4.8% |
| Depression |
2.4% |
| Erectile Dysfunction |
0.6% |
| Low Density Lipoprotein Increased |
0.6% |
|
| Renal Failure Acute |
56.3% |
| Abnormal Dreams |
6.3% |
| Drug Interaction |
6.3% |
| Fatigue |
6.3% |
| Hypovolaemia |
6.3% |
| Insomnia |
6.3% |
| Somnolence |
6.3% |
| Vomiting |
6.3% |
|